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Pseudomonas aeruginosa is a leading cause of nosocomial infections that are becaming 
increasing difficult to treat due to the occurrence of antibiotic resistant strains. Since P. 
aeruginosa virulence is controlled through quorum sensing, small molecule treatments 
inhibiting quorum sensing signaling pathways provide a promising therapeutic option. 
Consequently, we synthesized a series of N-octaneamino-4-aminoquinoline derivatives to 
optimize this chemotype’s anti-virulence activity against P. aeruginosa via inhibition of 
pyocyanin production. The most potent derivative, which possesses a benzofuran substituent, 
provided effective inhibition of pyocyanin production (IC50=12 μM), biofilm formation 
(BFIC50=50 μM), and motility. Experimentally, compound’s activity is achieved through 
competitive inhibition of PqsR, and structure-activity data was rationalized using molecular 
docking studies. 
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Pseudomonas aeruginosa, an opportunistic pathogen, poses a significant public health 
threat in the context of nosocomial infections, particularly in individuals with wither cystic 
fibrosis (CF), or immunocompromised patients (e.g., burn victims, cancer patients or patients 
with AIDS).1 Specifically, such P. aeruginosa infections are associated with high morbidity 
and mortality rates resulting from strains of the bacteria that are resistant to nearly all 
available antibiotics.2, 3 Recently, the World Health Organization classified P. aeruginosa as 
one of the most critical pathogens requiring the development of novel therapeutics.4
In this regard, alternative strategies to treat antibiotic resistant bacteria do not directly 
affect vital bacterial processes (e.g., cell wall synthesis), but rather, target virulence traits 
required to maintain pathogen presence in the host.5, 6 This tactic reduces evolutionary 
pathogen selection, thereby leading to a significant reduction in the development of 
resistance. With respect to the pathogenesis of P. aeruginosa infections, such treatment 
options afford the ability to inhibit the production of various cell-associated and secreted 
virulence factors that promote host invasion and tissue damage.7 Pyocyanin is one such 
important virulence factor, inducing cytotoxicity in different hosts by promoting the 
formation and release of reactive oxygen species.8-10 Another important virulence 
characteristic of P. aeruginosa stems from its ability to form biofilms, a thin layer of bacteria 
embedded in self-produced extracellular polymeric matrices.11 Subsequently, and not 
surprisingly, biofilm formation results in chronic infection, and leads to persistent 
inflammation and tissue damage.12 
Virulence factor production and biofilm formation are modulated through quorum 
sensing (QS).13 Therefore, interference with QS signaling is expected to repress the virulence 
factors’ production which in turn leads to attenuated infections that can be cleared due to 
increased susceptibility to antibiotics. 
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Quorum sensing entails the production of extracellular signaling molecules referred to 
as autoinducers (AI). The accumulation, detection, and response of bacteria to AIs regulates 
virulence and the expression of virulence genes. The QS system in P. aeruginosa consists of 
four interconnected and hierarchically organized signaling pathways: Las, Rhl, the PqsR-
controlled quinolone system (PQS), and the integrated QS system (IQS).14 Synthases LasI, 
RhlI, and PqsABCDEH produce 3-oxo-C12-homoserine lactone (3OC12-HSL), N-
butyrylhomoserine lactone (C4-HSL), and 4-hydroxy-2-alkylquinolones (HAQs), 
respectively, which are sensed by corresponding receptors LasR, RhlR, and PqsR. At high 
concentrations AIs bind to specific receptors and activate target genes encoding for virulence 
factors or synthases leading to the autoinduction of QS circuits. The LasR-3OC12-HSL 
complex activates the expression of elastase, alkaline protease, lipase, lasI itself, and rhlR. 
The RhlR-C4-HSL complex stimulates the production of rhamnolipids and biofilm 
formation, while concomitantly repressing the PQS system. Synthase PqsABCDEH produces 
2-heptyl-3-hydroxy-4-quinolone (PQS, Figure 1) and its precursor 2-heptyl-4-
hydroxyquinoline (HHQ, Figure 1), both of which are detected by the PqsR receptor.15, 16 
Formation of either the PqsR-PQS or the PqsR-HHQ complex triggers the transcription of the 
pqsABCDEH operon, leading to the synthesis of PQS and HHQ. PqsR also regulates the 
expression of rhlI and the production of several virulence factors, such as pyocyanin and 
hydrogen cyanide, as well as biofilm formation. The expression of pqsR is activated by LasR, 
but inhibited by RhlR.14 Hence, inhibitors of PqsR potently reduce virulence factor 
production and biofilm formation.17, 18 Moreover, the importance of HAQs for P. aeruginosa 
pathogenicity has been demonstrated in experimental animal infection models19 and in CF 
patients chronically infected with P. aeruginosa.20 Since there is an urgent need for more 
effective anti-P. aeruginosa therapeutics targeting the PQS pathway constitutes such a novel 
drug development strategy. 
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We have recently reported that long-chain 4-aminoquinolines (C12 derivatives, 2 and 
3, Figure 1) reduced biofilm formation and pyocyanin production in P. aeruginosa through 
interference with the PQS signaling pathway..17 Additionally, derivative 1 (C8 4-
aminoquinoline) reduced 3OC12-HSL levels, but showed no influence on HAQ production, 
which resulted in reduced biofilm formation, and increased pyocyanin production. In this 
study we have choosen 1 for further derivatization to elucidate key structural parameters 
required to inhibit the PQS signaling pathway and improve inhibitory activity against 









HHQ: R = H







1: n = 7, R = Cl
2: n = 11, R = Cl
3: n = 11, R = CF3
Figure 1. Structures of HHQ, PQS, and selected QS inhibitors.
RESULTS AND DISCUSSION
Chemistry 
We have synthetized 26 derivatives of 1 according to the reactions presented in Scheme 1S. 
Parent compound 1 was obtained starting from 4,7-dichlorquinoline and neat 1,8-
diaminooctane at 130 °C under inert atmosphere. Using various aryl- or alkyl-carbonyl 
compounds and NaBH4 in MeOH, 1 was transformed into corresponding N-benzyl 
derivatives 7 – 25 and 30 or N-alkyl derivatives 26 - 29. Derivatives 5 and 6 were prepared 
similarly to compound 1, using corresponding amines under elevated temperature. The new 
derivatives were designed to investigate the influence of modifications of basic character 
(i.e., alkyl- and acyl-substituent, respectively), steric demand (different alkyl-groups), and 
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electron-density of the terminal N-benzyl group on inhibition of various virulence factors 
production. NMR spectra are provided in the Supporting Information 1 (SI1).
|Pyocyanin and biofilm inhibition
All compounds were first assayed for effects on pyocyanin production and biofilm 
formation. The majority of compounds possessing substituted terminal aliphatic amino-
groups reduced pyocyanin levels in P. aeruginosa PA14, but with different efficacies (Table 
1, SI1 Figure S1). The exceptions were imidazole containing derivative 14, ,N,N-dimethyl 
group substituted 26, and N-isopropyl derivative 27, which provided no activity against 
pyocyanin production. Additionally, observed discrepancies included: 1) N-acyl derivative 5, 
which stimulated production of pyocyanin, suggesting that amine to amide transformation has 
agonistic effects, and 2) C8 alkyl chain containing derivative 6, which provided 80% 
reduction in pyocyanin level compared to DMSO control. The most active compounds were 
11, 12, 18, 19, 20, and 23, showing inhibition between 88% and 97%. Only four compounds, 
11, 16, 23, and 25, effectively reduced biofilm formation, with BFIC50 values (concentration 
of compound that inhibited biofilm formation by 50%) of 50 μM (Table 1). Importantly, the 
compounds showed no effect on bacterial growth at tested concentrations (SI1 Figure S1 and 
S2), most of them having MIC values above 2 mM (SI1 Table S1).
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Table 1. Effects of the compounds on pyocyanin (PYO) production, activities of QS 





























































































30±5 98±1 71±0.5 60±2 n.a.
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21±3 128±6 58±1 9±1 n.a.
aActivity of the compounds at 50 µM concentration; Values are presented as mean ± SD;
bBFIC50 – concentration of compound that inhibited biofilm formation by 50%; n.d. – not 
determined; n.a. – not active.
Previously we demonstrated that C12 4-aminoquinoline derivatives exhibited anti-QS 
activity through interference with the PQS signaling pathway, while 1 inhibited the  
production of 3OC12-HSL.17 To identify the biological target(s) of the novel derivatives 
presented herein, we evaluated their ability to competitively bind to QS receptors in the 
presence of exogenously provided autoinducers using P. aeruginosa biosensors (Table 1). P. 
aeruginosa PA14-R3, P. aeruginosa PAOJP2, and P. aeruginosa PAO1 ΔpqsA were used to 
measure LasR, RhlR, and PqsR activities, respectively. These biosensors cannot synthesize 
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respective AIs as their specific biosynthetic genes are deleted, and the light is detected only 
when exogenously provided AI activates the corresponding receptor.21-23 Most of the 
compounds that reduced pyocyanin production by more than 70% also showed strong 
inhibition of PqsR activity. The most prominent PqsR inhibition was observed for derivatives 
6 and 11, which also reduced the activity of RhlR. Out of 26 tested compounds, only 
derivative 13 acted as agonist on PqsR. This is an interesting finding given that its structural 
isomer, 12, acted as an antagonist. The good inhibitory activity of derivative 6 against 
pyocyanin production and PqsR challenged the necessity for the functionalization of the side 
chain. However, derivative 6 did not show inhibition of biofilm formation and had almost 
30% agonistic effect to LasR. Another N-benzyl derivatives also showed good activity 
against pyocyanin production and PqsR and to at least one of two other receptors and biofilm 
formation such as 16 (4-chlorobenzyl) and 23 (4-nitrobenzyl), without agonistic activity. 
Those results suggested that the presence of N-benzyl group is important for the activity of 
this group of compounds.
We further examined the influence of N-phenylethyl group and the modification of 
the side chain length on the compounds’ activity. Derivatives with N-phenylethyl group (30 
and 34), as well as derivative 33 with shorter alkyl-chain did not show significantly changed 
activity against pyocyanin production, biofilm formation, or interference with LasR or RhlR, 
comparing to derivative 7 (Table 1 and SI1 Table S2). Only derivative 34 exhibited stronger 
PqsR inhibition by 25%. Importantly, we observed significant rise in inhibitory activity 
against all indications with derivative 35 (C12-N-benzyl), most likely as a result of elongated 
alkyl-chain (SI1 Table S2).
Overall, the data presented in Table 1 suggests that the electronic properties of the 
aryl-group tethered to the quinoline have no direct influence on PqsR activity or pyocyanin 
production. Nevertheless, some structure-activity correlations are observed. For example, 
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halogen substituted derivatives are more active than other compounds – in general. 
Additionally, para-substituted N-benzyl isomers are less active than their positional isomers, 
as observed for 15 vs. 18 and 16 vs. 19 vs. 20, suggesting that the position of the halogen is 
important for activity. Similar correlations were obtained with MeO-substituted derivatives 9 
vs. 10, as well as with benzothiophen derivatives 12 vs. 13. Finally, the absence of distinct 
differences between electron-rich and electron-poor N-benzyl derivatives suggests that non-
bonded interactions (e.g., π-π stacking and weak π-hydrogen bonds) contribute significantly 
to the inhibition of PqsR activity, and consequently, to pyocyanin production, but that 
electronic within the aryl ring is not a major factor with respect to activity.
Quantitative structure property/activity relationship (QSPR and QSAR) and lipophilicity 
determination by reversed-phase thin-layer chromatography (RP-TLC)
Lipophilicity and other structural parameters have a great impact on the overall 
behavior of compounds in biological systems by influencing pharmacokinetics, 
pharmacodynamics, and ADMET profiles, and are closely related to cellular membrane 
permeability.24 Short chain AHLs are freely diffusible, long chain AHLs and HHQ require 
efflux pumps, while PQS is trafficked via membrane vesicles.25-27 In this study, to determine 
the lipophilicities of the compounds, and to examine the quantitative structure properties or 
quantitative structure-activity relationships (QSPR/QSAR) of the investigated compounds 
with respect to the inhibition of pyocyanin production, we used reversed-phase thin-layer 
chromatography (RP-TLC) and resulting retention parameters. This data is presented in 
Supporting Information 2 (SI2 Tables S6-S8). Linear dependences between RM values and 
Vol % of organic modifier in the mobile phase were established (SI1 Tables S10-S12, 
Graphic S2) and the RM0 were considered to be lipophilic parameters of the compounds.  
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Lipophilicity controls were also determined using interpolation and a calibration set of 
the compounds with known logP values. The partition coefficients of the investigated 
compounds were determined at pH 1, with mobile phase MeOH/H2O/HCl=60/35/5 (Vol %), 
and were presented as logDexp (SI2 Table S9).
The obtained results provided valuable information on the influence of structural 
modifications versus molecule lipophilicity (SI1). However, quantitative correlations of 
either logDexp or logDcalc(pH 7.4) (SI2 Table S9, Graphic S2) with the compounds’ activities, 
such as the inhibition of pyocyanin production or PqsR inhibition, were not observed. 
Specifically, a QSAR model was constructed to quantify the contributions of the 
structural features of derivatives with ability to inhibit pyocyanin production. However, the 
predictive ability of the obtained model was not significant (R2pred=0.561), and therefore it 
can only be interpreted qualitatively. Variables that had VIP>1.1 (Table 2, SI1 Table S4, SI2 
Graphic S10) were considered as significant, and the highest contribution to activity against 
pyocyanin production included SCIX3, SCIX4, SCIX5, CIQPlogS, WPSA, and mol MW. 
These results show that descriptors related to solvatation, water solubility, and molar mass 
contributed more to the inhibition of pyocyanin production than descriptors related to 
lipophilicity, e.g., QPlogPo/w and logD. Thus, the low influence of lipophilicity and the 
absence of a quantitative correlation of either logDexp or logDcalc. [QPlogPo/w, logDcalc(pH 
1.0) and logDcalc(pH 7.4), SI2 Table S9] with the inhibition of pyocyanin synthesis may 
suggest that the investigated compounds are transported through the cell membrane by 
facilitated transport rather than passive diffusion, especially since they are ionized at 
physiological pH.
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Table 2. The statistical performance of QSPR models correlating molecule descriptors with 
the inhibition of the pyocyanin synthesis in Pseudomonas aeruginosaa.






PLS1: 35.28% and 75.03%
PLS2: 20.30% and 7.64%
ALOGP2 (-), ACIX2 (+), SCIX3 (-), 
SCIX4 (-), SCIX5 (-), TCI3 (-), TCI4 
(-), CIQPlogS (+), PISA (-),  
QPlogKhsa (-), QPlogPo/w (-), WPSA 
(-), mol MW (-), logD (-)
aGraphics that illustrate obtained PLS models for contribution of structural descriptor to 
molecular lipophilicity and inhibition of pyocyanin production are provided in Graphic 9S. 
bFor abbreviation definitions and complete list of molecular descriptors see SI2.
Anti-virulence activity of selected compounds
Based on their activity against pyocyanin production and biofilm formation, and 
inhibition of PqsR, derivatives 11 and 12 were selected to further investigate how N-benzyl 
derivatization of 1 affects other QS-regulated virulence characteristics in P. aeruginosa. 
Compound 11 showed inhibitory activity against both pyocyanin production (concentration 
of compound that inhibited pyocyanin production by 50%, IC50=12 µM) and biofilm 
formation, while 12 strongly inhibited pyocyanin production (IC50=25 µM), but only weakly 
inhibited biofilm formation (Table 1). Compounds 1 and 11 dose-dependently reduced the 
formation of biofilms in concentrations up to 100 μM, and this effect was not increased by 
increasing dose (Figure 2A), while 12 showed only 20% reduction in biofilm formation, even 
at the highest applied concentration. Consistently, fluorescence microscopy showed that upon 
treatment of P. aeruginosa PAO1 with 11, only small viable cell aggregates could be 
observed, while extracellular polymeric matrix containing fluorescently stained extracellular 
DNA28 was less visible than in samples treated with 1, 12 or DMSO (Figure 2B).
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Figure 2. Effects of the compounds on biofilm formation. (A) Dose dependent inhibition of 
biofilm biomass measured by CV staining. All values were plotted relative to a DMSO-
treated control and presented as mean ± SD. *P < 0.05, **P < 0.001, ***P < 0.0001. (B) 
Fluorescent micrography of P. aeruginosa formed in the presence of 0.1% DMSO or 50 μM 
compound. Biofilms were grown for 24 h and stained with Syto9 (green) and PI (red). The 
scale bar represents 10 μm.
Additional virulence characteristics contributing to P. aeruginosa pathogenicity 
involve three types of motility, swimming, swarming, and twitching, which enable the 
bacteria to colonize different environments, and the production of elastases (hydrolytic 
enzymes that affect host cell proteins in infected tissues and facilitate bacterial invasion and 
growth).29, 30 Swarming and twitching motility, and elastase production are QS-regulated 
virulence characteristics, while swimming is QS-independent.31-33 At concentrations of 50 
μM, compounds 11 and 12 completely abolished twitching, while swarming and swimming 
were inhibited by 40% to 60% (Figures 3A and SI1 Figure S3). Parent compound 1 exhibited 
moderate effects on swarming and twitching motility, with inhibition rates of 30%, while 
swimming was stimulated by 80%. On the other hand, at a concentration of 50 μM, derivate 1 
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inhibited elastase production by 50%, while in the presence of 11 and 12 elastase activity was 
reduced by 35% and 30%, respectively (Figure 3B). 
Figure 3. Effects of selected compounds on P. aeruginosa (A) motility and (B) elastase 
production. All values are plotted relative to a DMSO-treated control and presented as mean 
± SD. *P < 0.05, **P < 0.001, ***P < 0.0001. 
The similar anti-virulence activities of 11 and 12 are likely due to their structural 
similarity, since their additional heterocyclic rings are sterically comparable, and both are 
electron enriched and could be involved in similar types of non-bonded interactions with the 
potential target. Although derivatives 11 and 12, compared to parent compound 1, showed 
improved anti-virulence activity, they both were cytotoxic in in vitro and in vivo assays (SI1 
Table S1, Figure S4). 
To closely examine the mechanism(s) responsible for the anti-QS activity of these 
derivatives, P. aeruginosa biosensor strains were incubated with increasing concentrations of 
selected compounds in the presence of exogenously provided natural AIs. Quorum sensing 
inhibitor Furanone C-3034 was used as a positive control (SI1 Figure S5). Compound 1 was 
only effective against PqsR activity, decreasing its functionality up to 35% depending on the 
dose (Figure 4). Derivatives 11 and 12 dose-dependently inhibited RhlR and PqsR. 
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Compound 12 showed considerable stimulatory effect on LasR at concentrations up to 100 
μM, while 11 significantly stimulated LasR activity only at 25 μM. Since 11 and 12 exhibited 
more  prominent repressive effect on PqsR (IC50 values of 25 μM and 30 μM, respectively) 
than RhlR (IC50 value of 40 μM for 11; IC50 not determined for 12 because of growth 
reduction at concentrations above 100 μM), and considering that the PQS system has a 
positive effect on Rhl system,35 it is likely that the primary target of these compounds is the 
PQS system. 
Figure 4. Effects of select compounds on the activity of QS receptors detected by 
bioluminescence measurements. All values are plotted relative to a DMSO-treated control 
and presented as mean ± SD. 
We further evaluated the effects of the compounds on the production of AIs using the 
same P. aeruginosa biosensors, but exogenously provided AIs extracted from P. aeruginosa 
PAO1 cultures upon growth in the presence of 50 μM of select compounds. In the presence of 
11 the quantity of HAQs in P. aeruginosa PAO1 culture supernatant was reduced by 60%, 
the amount of 3OC12-HSL was almost doubled, while C4-HSL level was not significantly 
changed (Table 3). Compound 12 inhibited only HAQ production, while 1 moderately 
reduced the amount of 3OC12-HSL, but slightly stimulated production of HAQs. These 
results confirmed that the primary target of 11 and 12 is the PQS signaling pathway via 
showing that inhibition of the PQS signaling pathway is required for successful inhibition of 
pyocyanin production. Moreover, 3OC12-HSL levels are in accordance with observed 
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stimulation of LasR (Table 1, Figure 4), and unchanged levels of C4-HSL, in spite of obvious 
inhibition of RhlR, could be explained by additional control of C4-HSL production via the 
LasR/LasI system.14, 36
Table 3. Production of autoinducers by P. aeruginosa PAO1 in the presence of 50 
μM compounds measured using specific P. aeruginosa biosensors.
Production (%)Compounda C4-HSL 3OC12-HSL PQS/HHQ
1 87±1 74±10 110±9
11 89±3 191±17 39±2
12 91±5 93±15 61±9
aValues are given relative to a DMSO-treated control and are average of three 
independent experiments ± SD.
Quantitative Real Time RT-PCR analysis was performed on total mRNA isolated 
from P. aeruginosa PAO1 cultured with select compounds to investigate their effects on the 
level of receptors’ (lasR, rhlR, and pqsR) and autoinducer synthases’ (lasI, rhlI, and pqsA) 
transcription. Evaluating changes greater than two-fold, we found that the compounds 
affected neither the receptors’ nor synthases’ transcription levels (SI Figure S6). Therefore, 
reduced levels of HAQs in the supernatants of 11 and 12 treated P. aeruginosa cultures could 
be a consequence of reduced functionality of PqsR and/or the enzymes required for quinolone 
biosynthesis. 
Taken together, these results show that inhibition of pyocyanin occurs as a result of 
the antagonistic binding of the compounds to PqsR.35 The activity of 11 and 12 against 
biofilm formation and elastase production could be a consequence of their additional 
inhibition of RhlR, while significant reduction of elastase production by 1 could be explained 
by its interaction with Las signalling pathway and reduced levels of 3OC12-HSL37 Different 
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effects of the compounds on the three QS signaling pathways involving agonistic or 
antagonistic activities, and the interconnection between the pathways resulted in overall 
different manifestation of P. aeruginosa virulence characteristics. 
Docking Simulations
Structure-based docking simulations were performed to rationalize the observed 
inhibitory activities for PqsR of the most active derivatives: 6, 11 and 12, and the parent 
compound 1. Derivative 6 inhibits PqsR activity by more than 90% (Table 1), and comprises 
structural fragments of synthesized derivatives, including a 4-aminoquinoline moiety, the n-
alkyl side chain of HHQ, PQS and synthetic antagonist 3-NH2-7Cl-C9-QNZ.38 
The docking simulation results indicated that the quinoline rings of 1, 6, 11, and 12 
occupy the same hydrophobic pocket of the receptor (Figure 5, SI1 Figure S8, S9, S12, S14). 
However their orientations depended on additional interactions with surrounding protein 
residues. For 1, the quinoline core achieved a NH-π interaction with Phe221 (2.53 Å), two 
halogen-H interactions with the side chains of Ser196 (OH-group, 2.85 Å) and the main chain 
NH of Leu197 (2.90 Å) (Figures 5A, SI1 Figure S8), and a strong H-bond with the main 
chain carbonyl groups of Asn206 and Arg209.
The modes of interaction for 11 and 12 with PqsR were almost identical (Figures 5B, 
SI1 Figures S8 and S9). However, the side chains of these compounds were oriented opposite 
to 1 due to the steric demands of their terminal N-substituents, and were additionally 
stabilized by hydrophobic interactions with the side chain residues of Leu207 and Ile263. 
Additional interactions with PqsR were: a) a H-bond between the protonated terminal amino-
group and the side chain carboxylate of Glu259 (11 1.59Å and 12 1.60Å), b) moderate H-
bonds between NH-C(4) and the main chain carbonyl of Leu207 (11 2.52Å and 12 2.92Å), c) 
halogen-H bond interactions with the side chain OH-group of Ser196 and the main chain NH 
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of Leu197, and d) π-H and π-π interactions with the main chain NH of Glu259 and Tyr258, 
respectively, and benzofuran/benzothiophene. 
Derivative 6 binding positioned the alkyl chain downward, compared to the side 
chains of 11 and 12 (Figures 5C and SI1 Figure S9), and therefore constitutes a third mode of 
ligand-PqsR bonding. Additionally, 6 formed a H-bond between NH-C(4) and the carbonyl of 
the main chain of Leu207 (2.36 Å).
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Figure 5. Docking of select compounds in the binding site of PqsR (PDB code 4JVI), with 
key amino acid residues emphasized in stick. A) Compound 1 (orange carbons). B) 
Compound 11 (cyan carbons) and 12 (orange carbons) binding predictions. C) Compound 6 
(purple carbons) binding prediction. For full ligand interaction diagrams see SI1 Figures S8 – 
S9.
Moreover,  modeling showed that the derivatives placed their quinolone rings into the same 
hydrophobic pocket as natural PqsR ligands, and synthetic antagonist 3-NH2-7Cl-C9-QNZ 38 
(SI1 Figures S10-S14). These three molecules also achieved additional interactions: a) 
hydrophobic interactions between their alkyl chains and the same region as derivative 6 (SI1 
Figure S9), and b) a H-bond with the main chain carbonyl group of Leu207, formed via N(1)-
H of HHQ (2.83Å), C(3)-OH of PQS (2.31Å) or N(3)-NH2 for 3-NH2-7Cl-C9-QNZ (1.93Å). 
These results support the experimental findings that 6, 11, and 12 inhibit PqsR by 
competing for the same binding site as natural ligands HHQ and PQS. We believe that the 
Glide emodel is more appropriate for comparison with the ligand-PqsR bonding mode than 
the GlideScore due to structural similarities of the compounds39. The Glide emodel values 
(SI1 Table S5) were completely in accordance with observed interactions in the presented 
models. However, they did not correlate with the observed inhibitory activities of examined 
compounds, native AIs, and 3-NH2-7Cl-C9-QNZ. This could be due to limited estimation of 
the entropy gain or loss upon binding. Second, observed scores were obtained through 
modeling with a sole receptor and approximation that of the entirety of the tested compound 
is present, which is not necessarily the case in biological systems. And finally, inhibition of 
PqsR activity comprises successive steps of conformational changes, including association of 
active complexes into dimers and further to tetramers, which makes the process demanding 
for modeling.
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The docking models revealed that most active compounds (6, 11, and 12) have 
different modes of receptor binding, which provide opportunities for developing quinoline-
based derivatives in different directions to obtain more active compounds.
Taken together, the models provide insights into possible interactions between PqsR 
and the derivatives presented herein, and may serve as to generate hypotheses for further, 
synthetic structural improvements. Importantly, the described model for the derivatives, and 
previous results for HHQ, PQS, and 3-NH2-7Cl-C9-QNZ,38 revealed the importance of an H-
bond with Leu207, suggesting that distance between ligand and Leu207 could be a measure 
of interaction strength.
Based on this general model, the proposed inhibition mechanism of PqsR with 
quinoline-based derivatives involves: a) occupation of a hydrophobic pocket with quinoline 
rings, formation of an H-bond with Leu207, and establishment of the above defined 
interactions of the compound side chains with the main or the side chain groups of 
surrounding protein residues, thereby preventing the binding of native AI’s to the active site, 
and thus activation of PqsR monomers, b) conformational changes of PqsR as a consequence 
of established interactions, and in the case of 11 and 12) position of the benzofuran or 
benzothiophene rings additionally prevents dimerization to active AQ-PqsR complexes and 
further formation of tetramers (and binding to DNA)40. A similar process to the latter was 
observed by modeling of structurally unrelated PqsR inhibitor M64, and experimentally 
confirmed by the X-ray structure of PqsR in complex with M64.41 Hence, simple insertion of 
quinoline rings and long alkyl-side chains into the active site is not sufficient for inhibition of 
PqsR, since many 2-alkyl-7-halogenquinolones showed agonistic activity38 implying that 
additional conformational changes are necessary for inhibitory activity.41 Considering the 
proposed models, significantly stronger interactions and improved inhibition of PqsR with 
quinoline-based derivatives versus 3-NH2-7Cl-C9-QNZ and congeners is expected. 
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However, the lower inhibitory activity of the tested quinoline derivatives could be the result 
of their probable lower bioavailability in comparison to M64 and 3-NH2-7Cl-C9-QNZ. This 
is in line with the high contribution of descriptors related to solvatation and solubility, thus 
suggesting that active compounds most likely require facilitated transport through cell 
membranes.
CONCLUSIONS
In summary, we have developed a new series of quinoline derivatives as antagonists 
of P. aeruginosa native AIs, with a broad anti-virulence activity established through 
interference with distinct QS signaling pathways. We showed that most of the compounds 
having N-benzyl substituted aliphatic terminal amino-group were able to reduce pyocyanin 
level through PqsR inhibition. The most active inhibitors of pyocyanin production and PqsR 
activity were 11 and 12, having benzofuran and benzothiophene substituents, respectively. 
Both 11 and 12 significantly reduced P. aeruginosa motility, suppressed production of 
HAQs, and showed moderate effects on elastase production, while 11 additionally reduced 
biofilm formation.
The results of QSAR analysis indicated that inhibition of pyocyanin production and 
PqsR activity simultaneously depended on several structural parameters, and that the 
solvation, connectivity, and aqueous solubility of the examined compounds have strong 
influence on activity. A lower contribution of lipophilicity and the absence of its quantitative 
correlation with the inhibition of pyocyanin production may suggest that the compounds are 
transported by efflux pumps rather than by passive diffusion. Molecular modeling studies 
showed that the quinoline rings of the examined derivatives occupied the same hydrophobic 
pocket of the PqsR receptor and formed critical H-bonds with Leu207, as observed for native 
AIs, while achieving additional interactions with surrounding protein residues. Specificially, 
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the compounds engaged in additional hydrophobic interactions through their N-substituted 
amino-alkyl chains, and hydrophobic and π-interactions through their alkyl chains and N-
benzyl substituents, respectively, and H-bonds or salt bridges via the protonated amines of 
their aliphatic amino groups. The binding models propose three different modes of interaction 
by the derivatives with PqsR, depending on the structure of compound side chain, and offers 
the possibility for the design and development of more potent PqsR inhibitors.
METHODS
Chemistry
Melting points were determined on a Boetius PMHK apparatus and were not corrected. 
Reactants were obtained from various suppliers and used without further purification. IR 
spectra were recorded on a Perkin-Elmer spectrophotometer FT-IR 1725X. 1H and 13C NMR 
spectra were recorded on a Bruker Ultrashield Advance III spectrometer (at 500 and 125 
MHz, respectively) employing indicated solvents using TMS as the internal standard.  
Chemical shifts are expressed in ppm (δ) values and coupling constants (J) in Hz. ESI-MS 
spectra were recorded on a LTQ Orbitrap XL instrument in positive ion mode by direct 
injection. Samples were dissolved in MeOH (HPLC grade purity). Selected values were as 
follows: capillary voltage 49 V, capillary temp 275 °C, vaporizer temp 60 oC, spray voltage 
4.2 kV, resolution (at m/z 400) 30000. TOF-MS spectra were recorded on a 4800 Plus 
MALDI TOF/TOF Analyzer, Applied Biosystems, US instrument Positive ion mode (fixed 
laser intensity 4280), with CH3CN/H2O gradient with 0.2% HCOOH as the carrying solvent 
solution. Samples were dissolved in MeOH (HPLC grade purity) mixed with CHCA (α-
Cyano-4-hydroxycinnamic acid) MALDI matrix (5 mg/mL in 50% acetonitril (v/v)). Internal 
calibrants: Azithromycin and Azithromycin fragments (m/z 156-749). Dry-flash 
chromatography was performed on 40-63 m and thin-layer chromatography (TLC) was 
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performed on precoated Merck silica gel 60 F254 and RP-18 F254 plates using UV light, 
cerium-ammonium molibdate (CAM) and Co(II)-thiocyanate for chromatogram visualization. 
Compounds were analyzed for purity (HPLC) using an Agilent Technologies 1260 liquid 
chromatograph equipped with quaternary pump (G1311B), injector (G1329B), 1260 ALS, 
TCC 1260 (G1316A), and detector 1260 DAD VL+ (G1315C). For data processing, LC 
OpenLab CDS ChemStation software was used. The HPLC purity of all synthetized 
compounds were >95% with exception of 30 which shows 87% and 88.45% purity. 
Microbial strains and growth conditions. Pseudomonas aeruginosa PAO1 NCTC 10332 
and P. aeruginosa PA14 were used in this study. Bacteria were grown in Luria Bertani (LB) 
broth on a rotary shaker at 180 rpm at 37 °C.
Antimicrobial susceptibility tests for planktonic cells. The minimum inhibitory 
concentrations (MIC) of compounds were determined according to standard broth 
microdilution assays recommended by the Clinical and Laboratory Standards Institute (M07-
A9) (CLSI, 2012). Stock solutions of the compounds were prepared in DMSO (200 mM). 
The highest tested concentration of any compound was 4 mM. The inoculums were 105 
colony forming units (CFU) mL-1. The MIC value corresponded to the lowest concentration 
that inhibited the visual growth after 20 h at 37 °C. DMSO was used for the growth control at 
the same concentration (up to 2%, v/v) as in the treatments. The assay was carried out in 
triplicate, and repeated twice.
Static biofilm formation inhibition assay. Biofilm quantification assays were performed in 
96-well microtiter plates using a crystal violet (CV) method to stain adherent cells.43 Biofilms 
formed for 24 h at 37 °C in the presence or absence of compounds were washed and adherent 
cells stained with 0.1% (v/v) CV. Each biofilm formation assay was performed in six wells 
and repeated at least three times.
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Pyocyanin assay was performed with P. aeruginosa PA14 as reported.44 Pyocyanin in the 
supernatant was quantified using a UV–vis spectrophotometer Ultrospec 3300pro (Amersham 
Biosciences, USA) at 695 nm. The experiment was performed in triplicate and repeated at 
least three times.
Elastase assay. The elastolytic activity in the supernatants of cultures incubated with the 
compounds or 0.1% DMSO was determined using the Elastin Congo Red (ECR) method.45 A 
100 μl aliquot of the cell-free supernatant was added to 900 μl of ECR buffer containing 5 mg 
of ECR (Sigma, Munich, Germany). The mixture was incubated on a rotary shaker for 12 h at 
37 °C. Insoluble ECR was removed and the absorption was measured at 485 nm. The 
experiments were performed in triplicate and repeated three times.
Motility assays. A swarming assay was performed on M8 plates containing 0.6% agar and 
either compound or DMSO. Plates were inoculated with 2.5 μL of the diluted Pseudomonas 
cultures (OD620 of 0.2), and the phenotype was observed and measured after 16 h incubation 
at 37 °C.46
Swimming motility was measured according to a previously described protocol.47  
Overnight cultures were diluted to OD620 of 0.2 and point-inoculated using toothpick bacteria 
onto M8 plates (5 g L-1 Na2HPO4, 3 g mL-1 KH2PO4, 0.5 g L-1 NaCl, 0.2% glucose, 0.5% 
casaminoacids and 1 mM MgSO4) containing 0.3% (w/v) agar and the compound. The plates 
were incubated for 18 h at 37 °C. The distance of colony migration around the inoculation 
site was evaluated by measuring the diameter of the covered areas.
Twitching motility was evaluated as previously described.48 Overnight Pseudomonas 
cultures were stabbed with a toothpick into LB plates supplemented with 1% agar and the 
compound, and incubated at 37 °C for 20 h followed by additional incubation for 72 h at 25 
°C. Bacterial migration along the plastic surface was detected and measured by CV (2%, 
(v/v)) staining after removing the agar from the plate. 
Page 24 of 31































































Interference of the compounds with QS pathways. Overnight cultures of biosensors P. 
aeruginosa PA14-R3 (ΔlasI Prsal::lux),21 PAOJP2/pKD-rhlA (ΔrhlA PrhlA::lux),22 and  P. 
aeruginosa PAO1 ΔpqsA (CTX lux::pqsA)23 were diluted to OD600=0.045, and incubated 
with 4-AQ derivatives in the presence of 5 M of specific autoinducers 3OC12HSL, C4-HSL 
and HHQ, respectively. Cell density (OD620) and bioluminescence (light counts per second, 
LCPS) were simultaneously measured after 4 h of incubation using Tecan Infinite200 
multiplate-reader (Tecan Group Ltd., Switzerland). Luminescence values were normalized 
per cell density. The assays were carried out in quadruplicate and repeated three times.
Fluorescent microscopy. Overnight cultures of bacteria were diluted to 5107 CFU mL-1 in 
LB and 2 mL were added per well of 6-well microtiter plates containing plastic cover slips in 
the presence of DMSO (0.1%) or BFIC50 concentrations of active compounds. After 24 h, 
biofilms were washed with 0.9% NaCl and stained with 2.5 µM SYTO9 green fluorescent 
dye and 2.5 µM propidium iodide (PI) red fluorescent dye (LIVE/DEAD® BacLight™ 
Bacterial Viability Kit, Thermo Fisher Scientific, Waltham, MA, USA). Cells were observed 
under a fluorescence microscope (Olympus BX51, Applied Imaging Corp., San Jose, USA) 
under 40× magnification.
Molecular modeling. Modeling of ligand-receptor interactions was performed using modules 
in Schrödinger Suite 2017-3 (Schrödinger, LLC, New York, NY, 2017). The structure of 
PqsR was generated from X-ray crystal structure PDB code 4JVI.38 The protein was prepared 
for docking simulations using the Protein Preparation Wizard (Schrödinger Suite 2017-3, 
Protein Preparation Wizard). The DNA molecule, second protein chain, ligand, and water 
molecules were removed, and the final structure achieved by minimization of hydrogen 
atoms with heavy atoms restrained. Structures of examined compounds were constructed 
using Maestro (Maestro, Schrödinger, LLC, New York, NY, 2017). The best conformations 
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were selected using Conformational search from MacroModel (OPLS_2005 force field with 
water as a solvent (MacroModel, Schrödinger, LLC, New York, NY, 2017)). 
Compound conformers were generated using a mixed torsional/low-mode sampling 
method, with an energy window of 10 kJ/mol. Every generated conformation was subjected 
to energy minimization using a Polak-Ribiere Conjugate Gradient method with 2500 
iterations or 0.05 convergence thresholds (whichever was achieved first) and duplicates were 
removed. Best conformers of every structure were used for generating molecular descriptors 
for QSAR calculations using QikProp module (QikProp, Schrödinger, LLC, New York, NY, 
2017). For docking in the protein, all structures were used as double protonated on the N-
atom of the quinoline ring, and the terminal amino group, in accordance with the 
experimental conditions of the PqsR inhibition assay (Epik, Schrödinger, LLC, New York, 
NY, 2017). Docking simulations were performed in Glide (Glide, Schrödinger, LLC, New 
York, NY, 2017), with standard precision (SP), enhancing the planarity of conjugated π 
groups, and post-docking minimization.
 Statistical analysis. The results were analyzed by Student’s t-test using SPSS version 20 
software. A P-value lower than 0.05 was considered statistically significant. 
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